BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2547032)

  • 1. Intra-arterial cisplatin for the treatment of malignant gliomas.
    Newton HB; Page MA; Junck L; Greenberg HS
    J Neurooncol; 1989 May; 7(1):39-45. PubMed ID: 2547032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of malignant gliomas: studies of the BTCG.
    Shapiro WR
    Rev Neurol (Paris); 1992; 148(6-7):428-34. PubMed ID: 1448662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic results of intra-arterial chemotherapy in patients with malignant glioma.
    Hirano Y; Mineura K; Mizoi K; Tomura N
    Int J Oncol; 1998 Sep; 13(3):537-42. PubMed ID: 9683790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intra-arterial cisplatin and 1,3-bis(2chloroethyl)-1-nitrosourea (BCNU) dosage on radiographic response and regional toxicity in malignant glioma patients: proposal of a new method of intra-arterial dosage calculation.
    Bobo H; Kapp JP; Vance R
    J Neurooncol; 1992 Jul; 13(3):291-9. PubMed ID: 1517805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. The CNS Cancer Consortium.
    Dropcho EJ; Rosenfeld SS; Morawetz RB; Vitek J; Brothers M; Gorum T; Bell S; Gillespie GY; Glantz M; Mahaley MS
    J Clin Oncol; 1992 Mar; 10(3):452-8. PubMed ID: 1311026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.
    Greenberg HS; Ensminger WD; Layton PB; Gebarski S; Meyer M; Chaffee B; Bender JF; Grillo-Lopez AJ
    Cancer Treat Rep; 1986 Mar; 70(3):353-7. PubMed ID: 3006913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure.
    Newton HB; Junck L; Bromberg J; Page MA; Greenberg HS
    Neurology; 1990 Nov; 40(11):1743-6. PubMed ID: 2172864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Individualized chemotherapy based on drug sensitivity and resistance assay and MGMT protein expression for patients with malignant glioma--analysis of 42 cases].
    Zhang JP; Shi HL; Sai K; Yue WY; Mu YG; Zhang XH; Chen ZP
    Ai Zheng; 2006 Dec; 25(12):1533-7. PubMed ID: 17166381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supraophthalmic carotid infusion with low dose cisplatin and BCNU for malignant glioma.
    Vance RB; Kapp JP
    J Neurooncol; 1986; 3(4):287-90. PubMed ID: 3958775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of supratentorial glioma with intracarotid cisplatin and intravenous carmustine].
    Rebollo J; Martín-Algarra S; Bilbao I; Zubieta JL; Calvo FA; de Castro P; Pastor MA; Viteri C; Martínez Lage JM
    Neurologia; 1990; 5(7):228-32. PubMed ID: 1963067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro analysis of BCNU-sensitivity in human malignant gliomas. II. Cross-resistance studies with cisplatinum and nitrosoureas.
    Gerosa MA; Rosenblum ML; Stevanoni G; Licata C; Della Corte V; Marcon C; Bricolo A; Tridente G
    Acta Neurol Scand; 1986 Jan; 73(1):66-70. PubMed ID: 3006422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas.
    Bradac GB; Soffietti R; Riva A; Stura G; Sales S; Schiffer D
    Neuroradiology; 1992; 34(1):73-6. PubMed ID: 1313161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraarterial infusion of carboplatin in the treatment of malignant gliomas: a phase II study.
    Follézou JY; Fauchon F; Chiras J
    Neoplasma; 1989; 36(3):349-52. PubMed ID: 2544815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supraophthalmic carotid infusion for recurrent glioma: rationale, technique, and preliminary results for cisplatin and BCNU.
    Kapp JP; Vance RB
    J Neurooncol; 1985; 3(1):5-11. PubMed ID: 2987427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients.
    Fernández-Hidalgo OA; Vanaclocha V; Vieitez JM; Aristu JJ; Rebollo J; Gúrpide A; Aramendía JM; Moreno-Palanques R; Martín-Algarra S; Subirá ML; Brugarolas A
    Bone Marrow Transplant; 1996 Jul; 18(1):143-9. PubMed ID: 8832007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors.
    Feun LG; Wallace S; Stewart DJ; Chuang VP; Yung WK; Leavens ME; Burgess MA; Savaraj N; Benjamin RS; Young SE
    Cancer; 1984 Sep; 54(5):794-9. PubMed ID: 6331626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluctuation of serum phenytoin concentrations during autologous bone marrow transplant for primary central nervous system tumors.
    Ghosh C; Lazarus HM; Hewlett JS; Creger RJ
    J Neurooncol; 1992 Jan; 12(1):25-32. PubMed ID: 1311752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial cisplatin in malignant brain tumors: incidence and severity of otic toxicity.
    Assietti R; Olson JJ
    J Neurooncol; 1996 Mar; 27(3):251-8. PubMed ID: 8847559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intra-arterial chemotherapy with ACNU in the treatment of malignant gliomas].
    Fujiwara T; Matsumoto Y; Tsuchida T; Honma Y; Mino S; Nagao S
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):489-95. PubMed ID: 1313668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated radiation therapy and concurrent cisplatin in malignant cerebral gliomas. Rapid palliation in low performance status patients.
    Hercbergs AA; Tadmor R; Findler G; Sahar A; Brenner H
    Cancer; 1989 Aug; 64(4):816-20. PubMed ID: 2472866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.